Notice is hereby provided under 35 U.S.C. §287(a) for the following products:
Illumina® MiSeqDx™ Cystic Fibrosis Assays | The listed products and their use are the subject of US Patent Nos. 6,201,107; 6,730,777; 6,984,487 and 6,902,907 licensed from The Regents of the University of Michigan and the HSC Research Development Limited Partnership. Updated |
---|---|
|
The listed products and their use are the subject of US Patent Nos. 6,201,107; 6,730,777; 6,984,487 and 6,902,907 licensed from The Regents of the University of Michigan and the HSC Research Development Limited Partnership. |
|
Limited Use Label License: This product and its use are the subject of one or more issued and/or pending US and foreign patent applications owned by Max Planck Gesellschaft, exclusively licensed to New England Biolabs, Inc. and sublicensed to Illumina, Inc. The purchase of this product from Illumina, Inc., its affiliates, or its authorized resellers and distributors conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product by the buyer (whether the buyer is an academic or for-profit entity). The purchase of this product does not convey a license under any claims in the foregoing patents or patent applications direct to producing the product. The buyer cannot sell or otherwise transfer this product or its components to a third party or otherwise use the product for the following COMMERCIAL PURPOSES: (I) use of the product or its components in manufacturing; or (2) use of the product or its components for therapeutic or prophylactic purposes in humans or animals. |
|
The listed products and their use are the subject of the following US Patent Nos. 7,375,234; 7,763,736; 8,129,542; 8,580,970; 8,877,939 and related patents and patent applications. |
|
The listed products and their use are the subject of the following US Patent Nos. 6,355,431; 6,429,027 and related patents and patent applications. |
|
US 7,414,116 US 7,329,860 US 7,589,315 US 7,960,685 US 8,039,817 US 8,071,962 US 8,158,926 US 8,244,479 US 8,315,817 US 8,412,467 US 8,725,425 US 8,914,241 US 8,921,073 US 8,965,076 US 9,012,022 US 9,068,220 US 9,121,063 US 9,365,898 US 9,415,368 US 9,512,422 US 9,752,186 |
|
US 7,414,116 US 7,329,860 US 7,589,315 US 7,960,685 US 8,039,817 US 8,071,962 US 8,158,926 US 8,241,573 US 8,244,479 US 8,315,817 US 8,412,467 US 8,914,241 US 8,951,781 US 8,965,076 US 9,068,220 US 9,121,063 US 9,365,898 |
|
US 7,414,116 US 7,329,860 US 7,589,315 US 7,960,685 US 8,039,817 US 8,071,962 US 8,158,926 US 8,244,479 US 8,315,817 US 8,412,467 US 8,725,425 US 8,914,241 US 8,921,073 US 8,965,076 US 9,012,022 US 9,068,220 US 9,121,063 US 9,365,898 US 9,415,368 US 9,512,422 US 9,752,186 |
|
US 7,414,116 US 7,329,860 US 7,589,315 US 7,960,685 US 8,039,817 US 8,071,962 US 8,158,926 US 8,244,479 US 8,315,817 US 8,412,467 US 8,914,241 US 8,965,076 US 9,012,022 US 9,068,220 US 9,121,063 US 9,193,996 US 9,365,898 US 9,410,977 US 9,540,690 US 9,752,186 US 9,777,325 US 10,005,083 US D781,870 |
|
US 7,414,116 US 9,012,022 US 9,193,996 US 9,410,977 US 9,540,690 US 9,752,186 US 9,777,325 US 10,005,083 US D781,870 US D794,211 |
|
US 7,414,116 US 7,329,860 US 7,589,315 US 7,960,685 US 8,039,817 US 8,071,962 US 8,158,926 US 8,241,573 US 8,244,479 US 8,315,817 US 8,412,467 US 8,422,031 US 8,446,573 US 8,914,241 US 8,965,076 US 9,012,022 US 9,068,220 US 9,121,063 US 9,365,898 US 9,410,977 US 9,512,422 US 9,540,690 US 9,777,325 US 10,005,083 |
|
US 7,414,116 US 8,906,320 |
|
US 7,414,116 US 7,329,860 US 7,589,315 US 7,960,685 US 8,158,926 |
|
US 7,414,116 US 7,329,860 US 7,589,315 US 7,960,685 US 8,158,926 |